BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2705789)

  • 1. [Metallothionein as a resistance factor for antitumor drugs].
    Imura N; Naganuma A; Satoh M
    Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):599-604. PubMed ID: 2705789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of metallothionein in cancer chemotherapy].
    Naganuma A; Imura N
    Gan To Kagaku Ryoho; 1994 Feb; 21(3):301-6. PubMed ID: 8109985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered cisplatin and cadmium resistance and cell survival in Chinese hamster ovary cells expressing mouse metallothionein.
    Koropatnick J; Pearson J
    Mol Pharmacol; 1993 Jul; 44(1):44-50. PubMed ID: 8341278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein-mediated resistance to multiple drugs can be induced by several anticancer drugs in mice.
    Okazaki Y; Miura N; Satoh M; Imura N; Naganuma A
    Biochem Biophys Res Commun; 1998 Apr; 245(3):815-8. PubMed ID: 9588197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis.
    Satoh M; Cherian MG; Imura N; Shimizu H
    Cancer Res; 1994 Oct; 54(20):5255-7. PubMed ID: 7923149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein induction and deinduction in human prostatic carcinoma cells: relationship with resistance and sensitivity to adriamycin.
    Webber MM; Rehman SM; James GT
    Cancer Res; 1988 Aug; 48(16):4503-8. PubMed ID: 3396002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein null cells have increased sensitivity to anticancer drugs.
    Kondo Y; Woo ES; Michalska AE; Choo KH; Lazo JS
    Cancer Res; 1995 May; 55(10):2021-3. PubMed ID: 7743495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of the expression of mouse metallothionein-I gene in human HeLa cell line on drug resistance].
    Li X; Lü W; Yin S; Li L
    Wei Sheng Yan Jiu; 2000 Jul; 29(4):199-201. PubMed ID: 12520915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 beta-mediated metallothionein induction and cytoprotection against cadmium and cis-diamminedichloroplatinum.
    Kondo Y; Kuo SM; Lazo JS
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1313-8. PubMed ID: 7932184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice overexpressing metallothionein are not resistant to adriamycin cardiotoxicity.
    DiSilvestro RA; Liu J; Klaassen CD
    Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):163-70. PubMed ID: 8884987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PF1070A, a novel and potent inducer of the synthesis of metallothionein.
    Asahi I; Miura N; Yamabe Y; Toyoda H; Imura N; Koyama M; Naganuma A
    Biochemistry; 1999 Aug; 38(32):10415-23. PubMed ID: 10441136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metallothionein].
    Naganuma A
    Nihon Rinsho; 1997 May; 55(5):1091-5. PubMed ID: 9155158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rottlerin stimulates metallothionein gene expression but inhibits metal transport in Chinese hamster ovary cells.
    Chen JH; Huang CH; Lin LY
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):256-63. PubMed ID: 11749125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.
    Naganuma A; Satoh M; Imura N
    Cancer Res; 1987 Feb; 47(4):983-7. PubMed ID: 3802104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothionein: a protein conferring resistance in vitro to tumor necrosis factor.
    Leyshon-Sørland K; Mørkrid L; Rugstad HE
    Cancer Res; 1993 Oct; 53(20):4874-80. PubMed ID: 8402675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallothionein expression and transient resistance to electrophilic antineoplastic drugs.
    Lazo JS; Basu A
    Semin Cancer Biol; 1991 Aug; 2(4):267-71. PubMed ID: 1912530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of buthionine sulfoximine-enhanced doxorubicin toxicity in metallothionein overexpressing transgenic mouse heart.
    Wu HY; Kang YJ
    J Pharmacol Exp Ther; 1998 Nov; 287(2):515-20. PubMed ID: 9808675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallothionein expression and resistance to cisplatin in a human germ cell tumor cell line.
    Koropatnick J; Kloth DM; Kadhim S; Chin JL; Cherian MG
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1681-7. PubMed ID: 8531144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone pretreatment enhances cellular sensitivity to cadmium despite a marked activation of the metallothionein gene.
    Shimada H; Hochadel JF; Waalkes MP
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):178-85. PubMed ID: 9007047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat hepatocytes with elevated metallothionein expression are resistant to N-methyl-N'-nitro-N-nitrosoguanidine cytotoxicity.
    Moffatt P; Plaa GL; Denizeau F
    Toxicol Appl Pharmacol; 1996 Jan; 136(1):200-7. PubMed ID: 8560476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.